Skip Navigation


Brain Advance Access originally published online on January 4, 2008
Brain 2008 131(2):438-446; doi:10.1093/brain/awm328
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
131/2/438    most recent
awm328v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lyoo, C. H.
Right arrow Articles by Lee, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lyoo, C. H.
Right arrow Articles by Lee, M. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2008). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Effects of disease duration on the clinical features and brain glucose metabolism in patients with mixed type multiple system atrophy

C. H. Lyoo1, Y. Jeong2, Y. H. Ryu3, S. Y. Lee1, T. J. Song1, J. H. Lee1, J. O. Rinne4 and M. S. Lee1

1Department of Neurology, Youngdong Severance Hospital, Yonsei University College of Medicine, Seoul, 2Department of Brain and Bioengineering, KAIST, Daejeon, 3Department of Radiology, Youngdong Severance Hospital, Yonsei University College of Medicine, Seoul, Korea and 4Turku PET Center, University of Turku, Turku, Finland

Correspondence to: Myung Sik Lee, MD, PhD, Professor, Department of Neurology, Youngdong Severance Hospital, 612 Eonjuro, Gangnam-gu, Seoul, Korea E-mail: mslee{at}yuhs.ac

To study the effect of disease duration on the clinical, neuropsychological and [18F]-deoxyglucose (FDG) PET findings in patients with mixed type multiple system atrophy (MSA), this study included 16 controls and 37 mixed-type MSA patients with a shorter than a 3-year history of cerebellar or parkinsonian symptoms. We classified the patients into three groups according to the duration of parkinsonian or cerebellar symptoms (Group I = ≤1 year; II = 13–24 months; III = 25–36 months). We performed UPDRS, international cooperative ataxia rating scale (ICARS), and a neuropsychological test battery. We compared the FDG PET findings of each group of patients with controls. Group I patients frequently had memory and frontal executive dysfunction. They showed hypometabolism in the frontal cortex, anterior cerebellar hemisphere and vermis. They had parkinsonian motor deficits, but no basal ganglia hypometabolism. Group II and III patients frequently had multiple domain cognitive impairments, and showed hypometabolism in the frontal and parieto-temporal cortices. Hypometabolism of the bilateral caudate and the left posterolateral putamen was observed in Group II, and whole striatum in Group III. In summary, the cortical hypometabolism begins in the frontal cortex and spreads to the parieto-temporal cortex in MSA. This spreading pattern coincides with the progressive cognitive decline. Early caudate hypometabolism may also contribute to the cognitive impairment. Parkinsonian motor deficits precede putaminal hypometabolism that begins in its posterolateral part. Cerebellar hypometabolism occurs early in the clinical courses and seems to be a relevant metabolic descriptor of cerebellar deficits.

Key Words: multiple system atrophy; cognitive impairment; positron emission tomography

Abbreviations: COWAT, controlled oral word association test; FDG, [18F]-deoxyglucose; FWHM, full-width half-maximum; GCI, glial cytoplasmic inclusion; ICARS, international cooperative ataxia rating scale; IQR, interquartile range; K-BNT, Korean version of the Boston naming test; MSA, multiple system atrophy; PET, positron emission tomography; RCFT, Rey–Osterrieth complex figure test; SVLT, Seoul verbal learning test; TE, echo time; TR, repetition time; UPDRS, unified Parkinson's disease rating scale.

Received September 10, 2007. Revised November 8, 2007. Accepted December 11, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.